New York State Common Retirement Fund’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-11,526
| Closed | -$1.18M | – | 3427 |
|
|
2023
Q2 | $1.18M | Sell |
11,526
-3,003
| -21% | -$284K | ﹤0.01% | 1696 |
|
|
2023
Q1 | $1.32M | Sell |
14,529
-5,307
| -27% | -$311K | ﹤0.01% | 1747 |
|
|
2022
Q4 | $754K | Sell |
19,836
-9
| -0% | -$310 | ﹤0.01% | 2115 |
|
|
2022
Q3 | $499K | Sell |
19,845
-799
| -4% | -$22.1K | ﹤0.01% | 2324 |
|
|
2022
Q2 | $627K | Buy |
20,644
+806
| +4% | +$24K | ﹤0.01% | 2251 |
|
|
2022
Q1 | $650K | Sell |
19,838
-6
| -0% | -$178 | ﹤0.01% | 2287 |
|
|
2021
Q4 | $523K | Sell |
19,844
-43
| -0.2% | -$3.33K | ﹤0.01% | 2417 |
|
|
2021
Q3 | $2M | Sell |
19,887
-3,813
| -16% | -$447K | ﹤0.01% | 1761 |
|
|
2021
Q2 | $3.35M | Sell |
23,700
-6,726
| -22% | -$760K | ﹤0.01% | 1551 |
|
|
2021
Q1 | $3.03M | Sell |
30,426
-2,500
| -8% | -$292K | ﹤0.01% | 1536 |
|
|
2020
Q4 | $4.07M | Sell |
32,926
-2,500
| -7% | -$329K | ﹤0.01% | 1340 |
|
|
2020
Q3 | $3.45M | Buy |
35,426
+900
| +3% | +$112K | ﹤0.01% | 1312 |
|
|
2020
Q2 | $5.39M | Buy |
34,526
+12,019
| +53% | +$1.83M | 0.01% | 1137 |
|
|
2020
Q1 | $3.25M | Sell |
22,507
-1,681
| -7% | -$325K | ﹤0.01% | 1218 |
|
|
2019
Q4 | $4.95M | Sell |
24,188
-500
| -2% | -$91.2K | 0.01% | 1257 |
|
|
2019
Q3 | $1.98M | Buy |
24,688
+807
| +3% | +$68.5K | ﹤0.01% | 1651 |
|
|
2019
Q2 | $2.25M | Buy |
23,881
+2,422
| +11% | +$209K | ﹤0.01% | 1597 |
|
|
2019
Q1 | $1.83M | Buy |
21,459
+3,033
| +16% | +$252K | ﹤0.01% | 1664 |
|
|
2018
Q4 | $1.03M | Buy |
18,426
+700
| +4% | +$42.7K | ﹤0.01% | 1892 |
|
|
2018
Q3 | $1.45M | Hold |
17,726
| – | – | ﹤0.01% | 1873 |
|
|
2018
Q2 | $620K | Buy |
17,726
+5,400
| +44% | +$164K | ﹤0.01% | 2358 |
|
|
2018
Q1 | $253K | Hold |
12,326
| – | – | ﹤0.01% | 2639 |
|
|
2017
Q4 | $349K | Buy |
12,326
+1,800
| +17% | +$50.2K | ﹤0.01% | 2515 |
|
|
2017
Q3 | $327K | Hold |
10,526
| – | – | ﹤0.01% | 2567 |
|
|
2017
Q2 | $333K | Buy |
10,526
+3,499
| +50% | +$86K | ﹤0.01% | 2620 |
|
|
2017
Q1 | $159K | Buy |
7,027
+1
| +0% | +$25 | ﹤0.01% | 2847 |
|
|
2016
Q4 | $153K | Hold |
7,026
| – | – | ﹤0.01% | 2859 |
|
|
2016
Q3 | $185K | Buy |
7,026
+2,000
| +40% | +$39.7K | ﹤0.01% | 2784 |
|
|
2016
Q2 | $99K | Buy |
+5,026
| New | +$97.7K | ﹤0.01% | 2997 |
|
Other funds holding RETA
New York State Common Retirement Fund's RETA Position: Q3 2023 in Review
New York State Common Retirement Fund sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 11,526 shares — an estimated $1.18M sold.
New York State Common Retirement Fund first reported a position in RETA in Q2 2016 and held it in 29 quarters. The position peaked at $5.39M in Q2 2020. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.
- New York State Common Retirement Fund reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- New York State Common Retirement Fund sold 11,526 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.18M.
- New York State Common Retirement Fund first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2016 and held it in 29 quarters.
- New York State Common Retirement Fund's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $5.39M in Q2 2020.
- 2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.
Based on New York State Common Retirement Fund's 13F filing for Q3 2023, filed 7 Nov 2023.